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EVALUATION OF PHARMACIST 
CLINICAL RECOMMENDATIONS IN  
A GERIATRIC HOSPITAL
Abstract
Objectives This study was undertaken to record 
the number and type of recommendations made by 
pharmacists reviewing the drug treatment of older 
patients, to note acceptance of these recommendations by 
physicians and to assess clinical significance of pharmacist 
recommendations.
Method Three pharmacists providing inpatient 
services at Zammit Clapp Hospital were asked to record 
specific details of all recommendations given using a 
designed documentation form. The clinical impact of 
the pharmacists’ recommendations was assessed by the 
pharmacists making the recommendations together 
with a panel of two independent pharmacists and a 
medical doctor who had to rate the contribution of each 
recommendation as major, moderate, minor or of no 
clinical significance.
Key findings A total of 263 valid pharmacist 
recommendations were documented. The most frequent 
recommendations, accounting for 20.5% (n=54) of the 
total number of recommendations were adjustment to 
dosage, frequency and time of administration followed 
by discontinuation of a medication. The majority of 
recommendations were accepted by physicians (80%) and 
were rated by the panel to be of moderate (60.5%) clinical 
significance.
Conclusion Clinical pharmacists make a number 
of recommendations of significant clinical benefit to the 
care of hospitalised elderly patients, the majority of which 
are accepted by physicians.
Keywords Interventions, Geriatric Pharmacy, 
Hospital Pharmacy, Clinical Pharmacy 
Introduction
The pharmacist has a knowledge of the optimal use 
of medications and the ability to influence physician 
prescribing.1 Studies have shown that interventions by 
hospital pharmacists are effective in reducing medication 
errors, improving patient health outcomes and decreasing 
both costs and length of stay.2-4 Significant and clinically 
important results can be achieved by pharmacists 
reviewing the drug treatment of older patients who are 
being hospitalised.5 
This study aimed to quantify and evaluate the impact of 
recommendations made by pharmacists at Zammit Clapp 
Hospital, a 60-bed hospital targeted for the treatment and 
rehabilitation of patients sixty years of age and older. The 
objectives of this study were to: record the number and 
type of recommendations made, note acceptance of the 
recommendations by physicians and assess the clinical 
significance of recommendations. 
Method
DOCUMENTATION FORM
 A documentation form was designed to standardise 
the recording of recommendations. It was created by 
combining aspects of other data sheets used in previous 
studies.6-8 The documentation form consisted of two 
parts: the first section for recording information including 
patient age and gender, the primary reason for admission 
and the patient’s number of chronic medications. The 
other section was created for describing the pharmacist 
recommendation, the drugs involved and to document 
whether the recommendation was accepted by the 
physicians.
PIlOT sTUDy
The documentation form and the study design were 
piloted in one ward for two weeks. Minor changes in 
wording and content were made to the form, which was 
then used throughout the study.
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DATA COllECTION 
During the actual study, each of the three pharmacists 
providing inpatient services at the hospital was asked to 
record specific details of all recommendations during a 
specified 12-week period. For the purposes of this study, 
the definition of a recommendation was “Any proactive or 
reactive activity made with the intent of improving patient 
management or therapy, involving the application of the 
pharmacist’s knowledge to a specific patient or physician 
order”.7, 9-11
AssEssMENT OF ClINICAl sIgNIFICANCE
The clinical impact of the pharmacists’ recommendations 
was assessed by the intervening pharmacist and a panel 
which consisted of two other clinical pharmacists and a 
medical doctor. All three evaluators were independently 
provided with the documentation forms. Evaluators had 
to rate the contribution of each recommendation as either 
major, moderate, minor or of no clinical significance. At 
least two of the three evaluators had to agree on the 
degree of significance of the recommendation. This gave 
rise to a single panel rating for each recommendation 
which was termed ‘the average significance’. 
sTATIsTICAl ANAlysEs
The documentation forms were coded and entered onto 
a Microsoft Office Excel 2007 spreadsheet to quantify 
and analyse the data. The data was then transferred to 
SPSS 15.0 to perform statistical evaluations and cross 
tabulations. The scores of the pharmacists coding their 
own recommendations, the physician and the evaluator 
pharmacists were compared using the paired-sample 
Student t-test.
Results
A total of 263 valid pharmacist recommendations to 158 
different patients were made during the study period.  
Some patients required more than one recommendation: 
(a mean of 1.7 recommendations were made per patient). 
The nature of recommendations is shown in Table 1.
ACCEPTANCE RATEs
Of the 263 recommendations, 80 per cent were accepted 
by physicians (n=211), 16 per cent were not accepted 
(n=43) and 3 per cent could not be evaluated for 
acceptance (n=9). Pharmacist recommendations classified 
as ‘Recommendation of monitoring’ had the highest 
percentage of accepted recommendations (93.3%) (n=245). 
The highest percentage of unaccepted recommendations 
was for the addition of a new medication (30.4%) (n=80).
sIgNIFICANCE
The majority of recommendations (60.5%) were rated to 
have provided an average significance in the moderate 
level (n=159), followed by recommendations of minor 
significance (35.4%) (n=93). Recommendations that were 
judged to have made a major contribution to the quality 
of patient care comprised 3% of recommendations (n=8). 
A relatively small percentage of recommendations (1.1%) 
(n=3) were judged to be of no clinical significance.
sTATIsTICAl ANAlysEs
There was no difference in the mean significance ranking 
scores between the two evaluator pharmacists (P=0.48; 
paired t-test). When the average significance of both 
evaluator pharmacists was compared with that attributed 
by the pharmacists coding their own recommendations, a 
significant difference resulted, (P<0.001; paired t-test) with 
the latter attributing higher significance than the evaluator 
pharmacists. The physician rated the highest percentage 
of recommendations as minor. This resulted in a poor 
agreement between the physician and the evaluator 
pharmacists in their assessment of the significance of 
recommendations (P<0.001; paired t-test). Overall, both the 
evaluator pharmacists and pharmacists coding their own 
recommendations rated the clinical significance of the 
recommendations higher than the physician.
“Clinical pharmacists make a number of 
recommendations of significant clinical benefit 
to the care of hospitalised elderly patients”
4Discussion
Adjustments of dosage, frequency and time of 
administration were the commonest reasons for 
pharmacist recommendations, followed by discontinuation 
of a medication. Thirty seven per cent (n=97) of the 
recommendations in these two categories featured 
central nervous system drugs, including benzodiazepines, 
antipsychotics and tricyclic antidepressants. The risks with 
these medications, enhanced by their concomitant use, 
are sedation, increased tendency to falls (and thus risks of 
fractures) and anticholinergic adverse effects, which are 
especially relevant in the older patient. The importance 
of these two categories can be interpreted in the light 
of polypharmacy, adverse drug reactions and decreased 
adherence to treatment in the elderly population.  
     
Physicians accepted advice on most of the 
recommendations proposed by pharmacists (80%), which 
confirms that pharmacists input is needed for high-quality 
care and that the pharmacists’ approach of therapy 
matched the practice adopted by the physicians. Of the 
unaccepted recommendations, reasons for not being 
accepted might be that a patient’s medication would 
have been commenced by a specialist and the physician 
would be reluctant to override another specialist’s initial 
prescribing decision,12  or the physician might not consider 
the recommendation a priority. Physicians would also 
sometimes know that patients would object to a change 
in their medications since they may have previously 
attempted and failed the strategy recommended by the 
pharmacist.       
 
The physician generally rated the recommendations as 
being of lower clinical relevance than the pharmacist 
did. This is consistent with findings in other studies.13, 14 
However although there was not an agreement on an 
individual case basis, both the evaluator pharmacists and 
pharmacists coding their own recommendations believed 
that overall, the highest percentage of recommendations 
were of moderate significance.
Conclusion 
This study provided several important insights. Clinical 
pharmacists make a number of recommendations that 
affect the care of hospitalised elderly patients, the majority 
of which were accepted by physicians and are of moderate 
clinical significance. Recommendations are aimed at 
improving quality of care and were judged to be mostly of 
moderate significance.
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Table 1   Recommendations according to category (n=263)
Category n (%)
Drug treatment initiated 23 (8.7)
Drug treatment discontinued 32 (12.2)
Recommendation of alternative therapy 21 (8.0)
Adjustment of dose / frequency / time of dose 54 (20.5)
Alteration of the formulation 17 (6.5)
Duration of therapy 31 (11.8)
Recommendation of monitoring 15 (5.7)
Identification of drug interaction / adverse drug event 6 (2.3)
Clarification of order – prescription sheet unclear / 
error in prescription sheet 20 (7.6)
Provision of drug information 15 (5.7)
Switch from regular to as-required 21 (8.0)
Investigate reason for a drug 5 (1.9)
Other 3 (1.1)
